DOI QR코드

DOI QR Code

The association of abdominal obesity, obesity and parathyroid hormone in Korean adults (aged≥50 years): The Korea National Health and Nutrition Survey, 2011

50세 이상 한국 성인에서 비만과 부갑상샘호르몬의 관련성 -2011 국민건강영양조사에 근거하여

  • Lee, Kyu Su (Radiological Science of Hanlyo University) ;
  • Yoon, Yo Sang (Radiological Science of Hanlyo University) ;
  • Yoon, Hyun (Biomedical laboratory science of Hanlyo University)
  • 이규수 (한려대학교 방사선학과) ;
  • 윤요상 (한려대학교 방사선학과) ;
  • 윤현 (한려대학교 임상병리학과)
  • Received : 2015.05.28
  • Accepted : 2015.06.11
  • Published : 2015.06.30

Abstract

The present study was conducted to assess the relationship between obesity and abdominal obesity and Parathyroid hormone (PTH) in adults aged 50 or older (n=3,305) using 2011 Korean National Health and Nutrition Examination Survey (KNHANES) data, which represents national data in Korea. Key study results were as follows: First, the PTH levels increased significantly with an increase in Body mass index (BMI) (p=0.003), shown by sIAD levels after adjusted the variables that affect sIAD levels (age, gender, SBP, DBP, and 25(OH)D). These were $66.25{\pm}0.89ng/dL$ for Normal weight (BMI, < $23.0kg/m^2$), $67.83{\pm}1.07 ng/dL$ for Overweight (BMI, $23.0-24.9kg/m^2$), $70.71{\pm}0.94ng/dL$ for Obesity (BMI,${\geq}25.0kg/m^2$). Second, the PTH level of abdominal obesity group ($69.30{\pm}0.80ng/dL$) was significantly higher (p=0.017) than non-abdominal obesity group ($66.63{\pm}0.74ng/dL$). In conclusion, BMI and waist measurement are positively associated with the PTH levels in Korean adults.

본 연구는 국가자료인 2011년도 국민건강영양조사 자료를 이용하여 50세 이상 성인에서 비만이 PTH에 미치는 영향을 평가하고자 실시하였다. 조사 참여자수는 8,518명이었고, 이중 50세 이상 성인 3,305명을 최종분석 대상자로 하였다. 본 연구의 주요결과는 PTH 평균값에 영향을 주는 관련변수(연령, 성별, SBP, DBP, 25(OH)D)를 보정 후, 정상군 (BMI, < $23.0kg/m^2$; $66.25{\pm}0.89ng/dL$)에 비하여 과체중군(BMI, $23.0-24.9kg/m^2$; $67.83{\pm}1.07 ng/dL$), 비만군(BMI,${\geq}25.0kg/m^2$; $70.71{\pm}0.94ng/dL$)의 PTH 평균값이 유의하게 증가하였고(p=0.003), Non-abdominal obesity군($66.63{\pm}0.74ng/dL$)에 비하여 Abdominal obesity군($69.30{\pm}0.80ng/dL$)의 PTH 평균값이 증가하였다(p=0.017). 결론적으로 비만과 복부비만은 PTH의 증가와 관련이 있다.

Keywords

References

  1. D. W. Haslam, W. P. James. "Obesity". Lancet, Vol.366, No.9492, pp.1197-209, 2005. DOI: http://dx.doi.org/10.1016/S0140-6736(05)67483-1
  2. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet, Vol.363, pp.157-163, 2004. DOI: http://dx.doi.org/10.1016/S0140-6736(03)15268-3
  3. R. H. Eckel. "Obesity: Mechanisms and Clinical Management", Philadelphia Lippincott Williams & Wilkins, 2003.
  4. National Statistics Office. 2008. Annul Report on the cause of Death Statistic. Republic of Korea.
  5. WHO. Obesity: Preventing and Managing the Global Epidemic Report of a WHO Consultation on obesity. Geneva; World Health Organization 2000.
  6. J. Silver, R. Levi. "Regulation of PTH synthesis and secretion relevant to the management of secondary hyperparathyroidism in chronic kidney disease", Kidney. Int, Suppl.95, S8-S12, 2005. DOI: http://dx.doi.org/10.1111/j.1523-1755.2005.09501.x
  7. R. L. Jilka, R. S. Weinstein, T. Bellido, P. Roberson, A. M. Parfitt, et, al. "Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone", J Clin Invest, Vol.104, pp.439-446, 1999. DOI: http://dx.doi.org/10.1172/JCI6610
  8. I. D. Boer, I. Gorodetskaya, B. Young, C. Y. Hsu, G. M. Chertow. "The severity of secondary hyperparathyroidism in chronic renal insufficiency in GFR-dependent, race-dependent, and associated with cardiovascular disease", J. Am. Soc. Nephrol, VOL.13, pp.2762-2769, 2002. DOI: http://dx.doi.org/10.1097/01.ASN.0000034202.91413.EB
  9. F. N. Saleh, H. Schirmer, J. Sundsfjord, R. Jorde. "Parathyroid hormone and left ventricular hypertrophy", Eur. Heart. J, Vol.24, pp.2054-2060, 2003. DOI: http://dx.doi.org/10.1016/j.ehj.2003.09.010
  10. M. L. Melamed, J. A. Eustace, L. Plantinga, B. G. Jaar, N. E. Fink, et, al. "Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal study", Kidney Int, Vol.70, pp.351-357, 2006. DOI: http://dx.doi.org/10.1038/sj.ki.5001542
  11. Z. Lagunova, A. C. Porojnicu, R. Vieth. "Serum 25-Hydroxyvitamin D Is a Predictor of Serum 1,25-Dihydroxyvitamin D in Overweight and Obese Patients", Pediatric diabetes, Vol.141 No.1, pp.112-117, 2011. DOI: http://dx.doi.org/10.3945/jn.109.119495
  12. The Fifth Korea National Health and Nutrition Examination Survey(KNHANES V-1), 2011, Korea Centers for Disease Control and Prevention.
  13. WHO. The Asia-Pacific Perspective: Redefining obesity and ots treatment. Sydney, Australia, Health Communications Australia Pty Ltd, 2000.
  14. WHO. "The Asia-Pacific Perspective: Redefinding obesity and ots treatment", Sydney, Australia, Health Communications Australia Pty Ltd, 2000.
  15. H. C. Hong, S. W. Kim, T. H. Kim, I. H. Cha, J. H. Ahn, et, al, "Successful Localization of Distant Metastasis in Parathyroid Carcinoma Using Intra-operative Parathyroid Hormone Assay", Endocrinol. Metab, Vol.26, No.1, pp.92-96, 2011. DOI: http://dx.doi.org/10.3803/EnM.2011.26.1.92
  16. Y. E. Kim. "The association between vitamin D deficiency and frailty syndrome", Journal of Korean life insurance medical association, Vol.26, No.1, pp.3-12, 2007.
  17. E. Hagstroom, P. Hellman, T. E. Larsson, E. I, Lars. B, J. Sundstroom, et, al. "Plasma Parathyroid Hormone and the Risk of Cardiovascular Mortality in the Community", Circulation, Vol.119, pp.2765-2771, 2007. DOI: http://dx.doi.org/10.1161/CIRCULATIONAHA.108.808733
  18. L. L. Schierbeck, T. S. Jensen, U. Bang, G. Jensen, L. Kober, et, al. "Parathyroid hormone and vitamin D-markers for cardiovascular and all cause mortality in heart failure", European Journal of Heart Failure, Vol.13, pp.626-632, 2011. DOI: http://dx.doi.org/10.1093/eurjhf/hfr016
  19. V. M. Brandenburg, M. G. Vervloet, N. Marx. "The role of vitamin D in cardiovascular disease: From present evidence to future perspectives", Atherosclerosis, Vol.225, No.2, pp.253-263, 2012. DOI: http://dx.doi.org/10.1016/j.atherosclerosis.2012.08.005
  20. S. B. Wang, Y. C. Cho. "Body Mass Index and Subsequent Risk of Hypertension, Hyperglycemia and Hypercholesterolemia in Health Checkup Examinees", Journal of the Korea Academia-Industrial cooperation Society, Vol.12, No.6, pp.2677-2684, 2011. https://doi.org/10.5762/KAIS.2011.12.6.2677
  21. S. Y. Lee, H. S. Park, D. J. Kim, J. H. Han, S. M. Kim, et, al. "Appropriate waist circumference cutoff points for central obesity in Korean adults", Diabetes Res. Clin. Pract, Vol.75, No.1, pp.72-80, 2007. DOI: http://dx.doi.org/10.1016/j.diabres.2006.04.013
  22. F. L. Brancati, N. Y. Wang, L. A. Mead, K. Y. Liang, M. J. Klag. "Body weight patterns from 20 to 49 years of age and subsequent risk for diabetes mellitus: the Johns Hopkins Precursors Study", Arch. Intern. Med, Vol.159, No.9, pp.957-963, 1991. DOI: http://dx.doi.org/10.1001/archinte.159.9.957
  23. E. E. Calle, M. J. Thun, J. M. Petrelli, C. Rodriguez, C. W. Jr. Heath. "Body-mass index and mortality in a prospective cohort of U.S. adults", N. Engl. J. Med, Vol.341, No.15, pp.1097-1105, 1999. DOI: http://dx.doi.org/10.1056/NEJM199910073411501
  24. B. H. Goodpaster, S. Krishnaswami, H. Resnick, D. E. Kelley, C. Haggerty, et, al. "Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women", Diabetes Care, Vol.26, No.2, pp.372-379, 2003. DOI: http://dx.doi.org/10.2337/diacare.26.2.372
  25. S. H. Suk, R. L. Sacco, B. Boden-Albala, J. F. Cheun, J. G. Pittman, et, al. "Abdominal obesity and risk of ischemic stroke", Stroke, Vol.34, No.7, pp.1586-1592, 2003. DOI: http://dx.doi.org/10.1161/01.STR.0000075294.98582.2F
  26. S. H. Lee, S. M. Kim, H. S. Park. "Serum 25-hydroxyvitamin D levels, obesity and the metabolic syndrome among Korean children", Nutrition, metabolism, and cardiovascular diseases, Vol.23, No.8, pp.785-791, 2013. DOI: http://dx.doi.org/10.1016/j.numecd.2012.04.013
  27. W. Saliba, O. Barnett-Griness, G. Rennert. "The relationship between obesity and the increase in serum 25(OH)D levels in response to vitamin D supplementation", Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, Vol.24, No.4, pp.144-1454, 2013. DOI: http://dx.doi.org/10.1007/s00198-012-2129-0
  28. G. E. Nam, D. H. Kim, K. H. Cho. "Estimate of a predictive cut-off value for serum 25-hydroxyvitamin D reflecting abdominal obesity in Korean adolescent", Nutrition research, Vol.32, No.6, pp.395-402, 2012. DOI: http://dx.doi.org/10.1016/j.nutres.2012.05.002
  29. S. A. Shapses, E. J. Lee, D. Sukumar, R. Durazo-Arvizu, S. H. Schneider. "The Effect of Obesity on the Relationship Between Serum Parathyroid Hormone and 25-Hydroxyvitamin D in Women", J Clin Endocrinol Metab, Vol.98, No.5, pp.E886-E890, 2013. DOI: http://dx.doi.org/10.1210/jc.2012-3369
  30. A. Guasch, M. Bullo, A. Rabassa, A. Bonada, D. D. Castillo, F. Sabench, J. Salas-Salvado. "Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study", Cardiovasc Diabetol, Vol.11, pp.149, 2012. doi: 10.1186/1475-2840-11-149. DOI: http://dx.doi.org/10.1186/1475-2840-11-149